Thierry B. Mauvernay
Voorzitter bij Debiopharm International SA
Oorsprong van het eerstegraads netwerk van Thierry B. Mauvernay
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Debiopharm International SA
 Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland.
20
| Subsidiary | Pharmaceuticals: Major | 20 |
Debiopharm Innovation Fund /Management/
 Debiopharm Innovation Fund /Management/ Investment ManagersFinance Debiopharm Innovation Fund SA develops, manufactures, and markets diagnostic systems. It seeks to invest in the biotechnology, diagnostics, and pharmaceutical industries with a focus on biomarker development, and large molecule capabilities. The firm mission is to invest in innovative diagnostic companies developing platforms and content to complement in-house diagnostic activities, give insight into cutting-edge diagnostics and facilitate access to new technologies. The company was founded in 1979 and is headquartered in Fribourg, Switzerland.
5
| Subsidiary | Investment Managers | 5 |
Institut d’Administration des Entreprises
2
| College/University | Other Consumer Services | 2 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Thierry B. Mauvernay via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| CATERPILLAR INC. | Trucks/Construction/Farm Machinery | Corporate Officer/Principal | |
Molecular Devices LLC
 Molecular Devices LLC Medical SpecialtiesHealth Technology Molecular Devices LLC engages in the provision of bioanalytical solutions for protein and cell biology in life science research, pharmaceutical, and bio-therapeutic development. Its product portfolio includes platforms for screening, genomic and cellular analysis, colony selection, and microplate detection. The company was founded by Harden M. McConnell in July, 1983 and is headquartered in San Jose, CA. | Medical Specialties | Director/Board Member | |
| SHIRE | Pharmaceuticals: Major | Corporate Officer/Principal | |
| BOBST GROUP SA | Industrial Machinery | Human Resources Officer | |
| BTG | Pharmaceuticals: Major | Corporate Officer/Principal | |
| BAINS DE MER DE MONACO | Hotels/Resorts/Cruise lines | Human Resources Officer | |
| BIOINVENT INTERNATIONAL AB | Biotechnology | Chief Tech/Sci/R&D Officer | |
Delta Biotechnology Ltd.
 Delta Biotechnology Ltd. Pharmaceuticals: OtherHealth Technology Part of Novonesis A/S, Delta Biotechnology Ltd. is a British company that produces and markets a range of valuable proteins from yeast using low-cost manufacturing technologies. The company is based in Windlesham, UK. Delta Biotechnology was acquired by Novozymes A/S on July 06, 2006. | Pharmaceuticals: Other | Director/Board Member | |
| INSEAD | College/University | Masters Business Admin | |
| University of Kiel | College/University | Doctorate Degree | |
| University of Strathclyde | College/University | Undergraduate Degree | |
| University College Dublin | College/University | Undergraduate Degree | |
Innomedica Oy
 Innomedica Oy Miscellaneous Commercial ServicesCommercial Services Innomedica is an international business consulting company serving the biotechnology and pharmaceutical industries. It provides a range of professional business development and project management services to its clients in both the public and private sectors. Innomedica's service portfolio includes Business Development, Licensing & Partnering, Japan Markets and Project Management. It is active on a global basis, though it specializes in the North European and Japanese markets. Its people are its main asset. Its success is based on leveraging the experience of professionals from different disciplines to deliver value to its clients. Its team portrays backgrounds from experienced business people to skilled lawyers and biomedical scientists. Innomedica was founded in 1997, and is a privately held company. Its client base covers both private and public sectors, both large and small. | Miscellaneous Commercial Services | Chief Executive Officer | |
| University of Warwick | College/University | Doctorate Degree Doctorate Degree | |
| University of Fribourg | College/University | Doctorate Degree | |
| Université Paris 1 Panthéon-Sorbonne | College/University | Doctorate Degree | |
| University of Geneva | College/University | Undergraduate Degree | |
| Swiss Federal Institute of Technology | College/University | Masters Business Admin Undergraduate Degree | |
| University of Lausanne | College/University | Corporate Officer/Principal Graduate Degree Masters Business Admin | |
| University of Bern | College/University | Corporate Officer/Principal | |
| Haute école spécialisée de Suisse occidentale University | College/University | Undergraduate Degree | |
| École des Hautes Études Commerciales de Paris | College/University | Masters Business Admin | |
| University of Helsinki | College/University | Graduate Degree | |
| University of Strasbourg | College/University | Doctorate Degree | |
Capital Investment & Brokerage Co.
 Capital Investment & Brokerage Co. Investment Banks/BrokersFinance Capital Investment & Brokerage Co. is a broker/dealer headquartered in Amman, Jordan. It was founded in 19995 and is a subsidiary of Capital Bank of Jordan (ASE: EXFB). The firm provides a range of brokerage services to various clients. | Investment Banks/Brokers | Analyst-Equity | |
| University of Lyon | College/University | Undergraduate Degree | |
Immunexpress Pty Ltd.
 Immunexpress Pty Ltd. Medical SpecialtiesHealth Technology Immunexpress Pty Ltd. engages in creating molecular diagnostics for sepsis. The company was founded by Roslyn Brandon, Mervyn Rees Thomas and Richard Bruce Brandon and in 2006 and is headquartered in Toowong, Australia. | Medical Specialties | Director/Board Member Director/Board Member | |
SOCAR Research SA
 SOCAR Research SA BiotechnologyHealth Technology SOCAR Research SA provides clinical research services. It provides services in the areas which include cardiovascular and related, cachexia, hematology, hypertension, metabolic, nephrology, nutraceuticals and oncology telemedicine. The firm's technology include e-SOCDAT is an e-clinical solution which provides e-design, e-data and e-data services. It serves the biotechnology, consumer healthcare, medical device, pharmaceutical, contract research organization and academic institutions. The company was founded in 1986 and is headquartered in Nyon, Switzerland. | Biotechnology | Corporate Officer/Principal | |
Anteis SA
 Anteis SA Medical/Nursing ServicesHealth Services Anteis SA modifies and functionalizes injectable hyaluronic acid for medical applications. The firm serves in Asthetic dermatology. The company was founded by Gilles Bos Gilles in March 2003 and is headquartered in Plan-les-Ouates, Switzerland. | Medical/Nursing Services | Chief Tech/Sci/R&D Officer | |
Biocartis SA
 Biocartis SA Medical SpecialtiesHealth Technology Biocartis SA develops molecular diagnostic solutions. It focuses on Oncology. The firm’s products include Idylla and Oncology assays and mutation tests. It also provides instant access to personalized medicine for patients. The company was founded by Rudi Pauwels in 2007 and is headquartered in Lausanne, Switzerland. | Medical Specialties | Director/Board Member Director/Board Member | |
| Debio Recherche Pharmaceutique SA | President | ||
| Mercuri Urval AG | Corporate Officer/Principal | ||
Soc Exploi Telepher Tarentaise Maurienne
 Soc Exploi Telepher Tarentaise Maurienne Movies/EntertainmentConsumer Services Part of Savoie Stations Participation, Soc Exploi Telepher Tarentaise Maurienne operates cable cars and ski lifts. The company is based in Les Belleville, France. The CEO of the French company is Jérôme Nizier Armand Grellet. | Movies/Entertainment | Director/Board Member | |
| BERGENBIO ASA | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Universidad del Rosario | College/University | Doctorate Degree | |
| NUCANA PLC | Biotechnology | Chief Operating Officer | |
Med Discovery SA
 Med Discovery SA BiotechnologyHealth Technology Med Discovery SA is a Swiss biopharmaceutical company that develops treatments for cancers. The private company was founded by David Luc Deperthes. | Biotechnology | Founder Corporate Officer/Principal | |
Centre Hospitalier Universitaire Vaudois
 Centre Hospitalier Universitaire Vaudois Hospital/Nursing ManagementHealth Services Centre Hospitalier Universitaire Vaudois is a university hospital located in Lausanne, CH. The SwitzerlandUV is also a renowned center of medical education and research, collaborating with the Faculty of Biology and Medicine of the University of Lausanne and the Swiss Federal Institute of Technology in Lausanne (EPFL). It has 16 clinical and medico-technical departments and is known for its academic achievements in healthcare, research, and teaching. The vast campus in the lake region is home to these institutions. The CEO of the Swiss company is Nicolas Demartines. | Hospital/Nursing Management | Corporate Officer/Principal | |
Immunexpress, Inc.
 Immunexpress, Inc. Miscellaneous Commercial ServicesCommercial Services Immunexpress, Inc. engages in development of revolutionary molecular diagnostics. The firm's SeptiCyte technology quantifies specific and multiple molecular markers from the patient?s own immune system for earlier detection and severity assessment of sepsis, as well as the better timing of drugs and other therapies. The company was founded by Richard Bruce Brandon, Roslyn Brandon and Mervyn Rees Thomas in and is headquartered in | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| BIOCARTIS GROUP NV | Medical Specialties | Director/Board Member Director/Board Member | |
Kaiku Health Oy
 Kaiku Health Oy Information Technology ServicesTechnology Services Kaiku Health Oy engages in the provision of digital health interventions for cancer patients. It offers patient-reported outcome monitoring and intelligent system tracking. The company was founded by Kaarlo Haikonen, Joel Lehikoinen, Henri Virtanen, Otto Seiskari and Lauri Sippola in 2012 and is headquartered in Helsinki, Finland. | Information Technology Services | Chairman | |
Dynacure SA
 Dynacure SA Medical/Nursing ServicesHealth Services Dynacure SA is a clinical-stage company, which engages in developing and commercializing novel therapies to transform the lives of patients with rare diseases who have limited or no treatment options. Its product includes, DYN101, an antisense oligonucleotide, or ASO, designed to be a disease-modifying medicine for treatment of the majority of ntronuclear myopathies patients with multiple mutations in adult and pediatric populations. The company was founded by Belinda Cowling in 2016 and is headquartered in Illikirch-Graffenstaden, France. | Medical/Nursing Services | Chief Tech/Sci/R&D Officer | |
Iktos SAS
 Iktos SAS Packaged SoftwareTechnology Services Iktos SAS is a French company that specializes in generative modeling for drug discovery. The company is based in Paris, France and was founded in 2016 by Nicolas Do Huu, Yann Gaston-Mathé, and Quentin Perron. The company's offerings include professional services, research collaborations, partnerships, and software and SaaS licenses. The company's innovative technology platform includes generative modeling solutions with built-in synthetic accessibility. Contact them at contact@iktos.com for more details. Yann Gaston-Mathé has been the CEO since 2016. | Packaged Software | Director/Board Member | |
Novadiscovery SAS
 Novadiscovery SAS Information Technology ServicesTechnology Services Novadiscovery SAS develops mathematical model and artificial intelligence solutions for the healthcare sector. It offers risk management analytic tools for medical research programs and clinical trials. The company was founded by Fr?d?ric Cogny, Jean-Pierre Boissel, and Fran?ois-Henri Boissel in 2010 and is headquartered in Lyon, France. | Information Technology Services | Director/Board Member | |
| VIRAX BIOLABS GROUP LIMITED | Financial Conglomerates | Chief Operating Officer |
Statistieken
Internationaal
| Zwitserland | 18 |
| Frankrijk | 10 |
| Verenigd Koninkrijk | 7 |
| Verenigde Staten | 4 |
| Finland | 4 |
Sectoraal
| Consumer Services | 20 |
| Health Technology | 17 |
| Commercial Services | 4 |
| Health Services | 4 |
| Technology Services | 4 |
Operationeel
| Director/Board Member | 43 |
| Corporate Officer/Principal | 31 |
| Undergraduate Degree | 10 |
| Doctorate Degree | 8 |
| Chief Tech/Sci/R&D Officer | 7 |
Sterkste connecties
- Beurs
- Insiders
- Thierry B. Mauvernay
- Bedrijfsconnecties
